- Home
- LVLU vs RFL Comparison
LVLU vs RFL Comparison
Compare LVLU & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- RFL
- Stock Information
- Founded
- LVLU 1996
- RFL 2017
- Country
- LVLU United States
- RFL United States
- Employees
- LVLU N/A
- RFL N/A
- Industry
- LVLU Catalog/Specialty Distribution
- RFL Real Estate
- Sector
- LVLU Consumer Discretionary
- RFL Finance
- Exchange
- LVLU Nasdaq
- RFL Nasdaq
- Market Cap
- LVLU 50.4M
- RFL 55.3M
- IPO Year
- LVLU 2021
- RFL N/A
- Fundamental
- Price
- LVLU $1.11
- RFL $1.92
- Analyst Decision
- LVLU Hold
- RFL
- Analyst Count
- LVLU 3
- RFL 0
- Target Price
- LVLU $1.58
- RFL N/A
- AVG Volume (30 Days)
- LVLU 34.4K
- RFL 30.6K
- Earning Date
- LVLU 11-13-2024
- RFL 01-03-2025
- Dividend Yield
- LVLU N/A
- RFL N/A
- EPS Growth
- LVLU N/A
- RFL N/A
- EPS
- LVLU N/A
- RFL N/A
- Revenue
- LVLU $324,699,000.00
- RFL $697,000.00
- Revenue This Year
- LVLU N/A
- RFL N/A
- Revenue Next Year
- LVLU $1.86
- RFL N/A
- P/E Ratio
- LVLU N/A
- RFL N/A
- Revenue Growth
- LVLU N/A
- RFL 151.62
- 52 Week Low
- LVLU $0.97
- RFL $1.29
- 52 Week High
- LVLU $2.22
- RFL $2.50
- Technical
- Relative Strength Index (RSI)
- LVLU 43.66
- RFL 53.58
- Support Level
- LVLU $0.97
- RFL $1.71
- Resistance Level
- LVLU $1.16
- RFL $1.92
- Average True Range (ATR)
- LVLU 0.10
- RFL 0.10
- MACD
- LVLU 0.01
- RFL -0.00
- Stochastic Oscillator
- LVLU 50.00
- RFL 84.00
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.